Access to Medicines for Treating People With Cryptococcal Meningitis.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 36037037.
- Also identified by DOI 10.1093/cid/ciac689 and PMC identifier 7614173.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cryptococcal meningitis accounts for 1 in 5 AIDS-related deaths globally. World Health Organization guidelines strongly recommend a single high dose of liposomal amphotericin B as part of preferred treatment, but this drug remains unaffordable in most low- and middle-income countries. A proactive approach is needed from manufacturers and other stakeholders to improve access.
Medical subject headings
- Meningitis, Cryptococcal